"In a bid to have the right to purchase high-purity omega-3 supplements stripped from US consumers, Amarin attempted to circumvent the jurisdiction granted by Congress" to FDA, says Medical Research Collaborative in petition. The author also has reviewed Amarin's business results and has been critical of its stability.
A health care industry analyst makes no bones about why he's asking the US Food and Drug Administration to formally categorize some forms of omega-3 fatty acids as dietary ingredients.
"In a bid to have the right to purchase high-purity omega-3 supplements stripped from U.S. consumers, Amarin Corp. attempted to...